Seven-membered ring compounds as inhibitors of cytidine deaminase
US4275057A · kind A · utility
10Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 1980 |
| Grant date | Jun 23, 1981 |
| Priority date | — |
| Expiry date | Jan 28, 2000 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/052
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Seven-membered heterocyclic nucleosides used to inhibit the deamination enzyme responsible for the inactivation of arabinosylcytosine (ara--C). Preferred nucleosides containing a seven-member aglycone are as follows: ##STR1## Preferred aglycones are as follows: ##STR2## Active components utilized against pyrimidine deaminases from mammalian tissues (mouse kidney and human liver) showed optimum advantage when compared with tetrahydrouridine (THU).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.